DBV TECHNOLOGIES |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.222 EUR | +1.50% |
|
-1.77% | -33.91% |
DBV Technologies specializes in developing solutions for diagnosing and treating food allergies (primarily to peanuts and cow's milk) using a patch (Viaskin®) that administers active ingredients into the top layers of the skin.
Sector
Pharmaceuticals
Calendar
2024-05-16
- Annual General Meeting
Trading Rating
Investor Rating
ESG Refinitiv
C-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
1.222
EUR
Average target price
4.783
EUR
Spread / Average Target
+291.43%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -33.91% | 125M | |
| +6.52% | 71.18B | |
| +13.33% | 9.23B | |
| -11.55% | 5B | |
| +48.05% | 4.46B | |
| +5.09% | 3.95B | |
| -14.74% | 2.54B | |
| +20.00% | 2.44B | |
| -24.89% | 2.36B | |
| +21.45% | 2.18B |
- Stock Market
- Equities
- DBV Stock
- Funds and ETFs DBV Technologies